The additivity of substrate fragments in enzyme-ligand binding

被引:68
作者
Stout, TJ
Sage, CR
Stroud, RM [1 ]
机构
[1] Univ Calif San Francisco, Sch Med, Dept Biochem, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Sch Med, Dept Biophys, San Francisco, CA 94143 USA
来源
STRUCTURE WITH FOLDING & DESIGN | 1998年 / 6卷 / 07期
关键词
drug design; modular ligand binding; substrate fragments; substrate recognition; X-ray crystallography;
D O I
10.1016/S0969-2126(98)00086-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Enzymes have evolved to recognise their target substrates with exquisite selectivity and specificity. Whether fragments of the substrate perhaps never available to the evolving enzyme - are bound in the same manner as the parent substrate addresses the fundamental basis of specificity. An understanding of the relative contributions of individual portions of ligand molecules to the enzyme-binding interaction may offer considerable insight into the principles of substrate recognition, Results: We report 12 crystal structures of Escherichia coli thymidylate synthase in complexes with available fragments of the substrate (dUMP), both with and without the presence of a cofactor analogue. The structures display considerable fidelity of binding mode and interactions. These complexes reveal several interesting features: the cofactor analogue enhances the localisation of substrate and substrate fragments near the reactive thiol; the ribose moiety reduces local disorder through additional specific enzyme-ligand interactions; the pyrimidine has multiple roles, ranging from stereospecificity to mechanistic competence; and the glycosidic linkage has an important role in the formation of a covalent attachment between substrate and enzyme. Conclusions: The requirements of ligand-protein binding can be understood in terms of the binding of separate fragments of the ligand. Fragments which are subsystems of the natural substrate for the enzyme confer specific contributions to the binding affinity, orientation or electrostatics of the enzymatic mechanism. This ligand-binding analysis provides a complementary method to the more prevalent approaches utilising site-directed mutagenesis. In addition, these observations suggest a modular approach for rational drug design utilising chemical fragments.
引用
收藏
页码:839 / 848
页数:10
相关论文
共 38 条
  • [1] A novel dCMP methylase by engineering thymidylate synthase
    Agarwalla, S
    LaPorte, S
    Liu, L
    Finer-Moore, J
    Stroud, RM
    Santi, DV
    [J]. BIOCHEMISTRY, 1997, 36 (50) : 15909 - 15917
  • [2] ALISON DL, 1985, CANCER CHEMOTH PHARM, V14, P265
  • [3] Brunger A. T., 1992, X PLOR VERSION 3 1 S
  • [4] A C-TERMINAL CONFORMATIONAL EQUILIBRIUM IN THYMIDYLATE SYNTHASE OBSERVED BY ELECTRON-PARAMAGNETIC-RESONANCE SPECTROSCOPY
    CARRERAS, CW
    NABER, N
    COOKE, R
    SANTI, DV
    [J]. BIOCHEMISTRY, 1994, 33 (08) : 2071 - 2077
  • [5] THE CATALYTIC MECHANISM AND STRUCTURE OF THYMIDYLATE SYNTHASE
    CARRERAS, CW
    SANTI, DV
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1995, 64 : 721 - 762
  • [6] DEV IK, 1992, M AM ASS CANC RES, P2429
  • [7] DUCH DS, 1993, CANCER RES, V53, P810
  • [8] REFINED STRUCTURES OF SUBSTRATE-BOUND AND PHOSPHATE-BOUND THYMIDYLATE SYNTHASE FROM LACTOBACILLUS-CASEI
    FINERMOORE, J
    FAUMAN, EB
    FOSTER, PG
    PERRY, KM
    SANTI, DV
    STROUD, RM
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1993, 232 (04) : 1101 - 1116
  • [9] PAIRWISE SPECIFICITY AND SEQUENTIAL BINDING IN ENZYME CATALYSIS - THYMIDYLATE SYNTHASE
    FINERMOORE, JS
    MONTFORT, WR
    STROUD, RM
    [J]. BIOCHEMISTRY, 1990, 29 (30) : 6977 - 6986
  • [10] THE MEASUREMENT OF POLYGLUTAMATE METABOLITES OF THE THYMIDYLATE SYNTHASE INHIBITOR, ICI-D1694, IN MOUSE AND HUMAN CULTURED-CELLS
    GIBSON, W
    BISSET, GMF
    MARSHAM, PR
    KELLAND, LR
    JUDSON, IR
    JACKMAN, AL
    [J]. BIOCHEMICAL PHARMACOLOGY, 1993, 45 (04) : 863 - 869